Last update 16 Oct 2026

TVAX-008

Overview

Basic Info

Drug Type
Therapeutic vaccine
Synonyms
TVAX 008, TVAX008
Target
HBcrAg x L-HBsAg
Action
inhibitors, stimulants
Mechanism
HBcrAg inhibitors(HBcrAg inhibitors), L-HBsAg inhibitors(L-HBsAg inhibitors), Immunostimulants
Therapeutic Areas
Infectious DiseasesDigestive System Disorders
Active Indication
Hepatitis B, Chronic
Inactive Indication-
Originator Organization
Grand Theravac Life Science Nanjing Co. Ltd.Grand Theravac Life Science Nanjing Co. Ltd.
Active Organization
Grand Theravac Life Science Nanjing Co. Ltd.Grand Theravac Life Science Nanjing Co. Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 3
First Approval Date-
RegulationBreakthrough Therapy (China)
Login to view timeline

Related

11
Clinical Trials associated with TVAX-008
NCT07876856
/ Not yet recruitingPhase 1/2
A Randomized, Double-blind, Placebo-Controlled, Multicenter Phase 1/2 Study to Evaluate AHB-137 Injection Followed by TVAX-008 Injection in Participants With HBeAg-Negative Chronic Hepatitis B Treated With Nucleos(t)Ide Analogs
NCT07282249
/ Not yet recruitingPhase 3
A Multicenter, Randomized, Placebo-Controlled and Positive-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in the Treatment of Chronic Hepatitis B
NCT07179653
/ Active, not recruitingPhase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in Chronic Hepatitis B Patients
100 Clinical Results associated with TVAX-008
Login to view more data
100 Translational Medicine associated with TVAX-008
Login to view more data
100 Patents (Medical) associated with TVAX-008
Login to view more data
100 Deals associated with TVAX-008
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hepatitis B, ChronicPhase 3-
Grand Theravac Life Science Nanjing Co. Ltd.Grand Theravac Life Science Nanjing Co. Ltd.
31 Dec 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free